Ascites is the pathologic accumulation of fluid in the peritonealcavity. The condition develops most frequently as part of thedecompensation of previously asymptomatic chronic liver disease(Table 1). Ascites is the most common complication of such disease,occurring in 50 percent of patients within 10 years of a diagnosisof compensated cirrhosis; in comparison, variceal bleeding developsin only 25 percent2. The development of fluid retention in aperson with chronic liver disease is a poor prognostic sign;only 50 percent of such people survive two years3. The prognosisof patients with noncirrhotic ascites is . . . [Full Text of this Article]
Abdominal Paracentesis and Analysis of Ascitic Fluid
Treatment of Patients with Cirrhosis and Ascites
Diuretic-Resistant Ascites
Source Information
From the Department of Internal Medicine, University of Iowa College of Medicine, Iowa City.
Address reprint requests to Dr. Runyon at the Division of Gastroenterology/Hepatology, Department of Medicine, University of Louisville, Louisville, KY 40292.
References
Related Letters:
Care of Patients with Ascites
Kaufman J. L., Gerbes A.L., Scholmerich J., Montero E., Miguel J., Lopez-Alvarez J., Runyon B. A.
Extract |
Full Text
N Engl J Med 1994;
330:1827-1828, Jun 23, 1994.
Correspondence
This article has been cited by other articles:
MacLaren, R.
(2009). Management of Cirrhosis and Associated Complications. Journal of Pharmacy Practice
22: 290-309
[Abstract]
Javle, M., Abernethy, A., Busaidy, N. L., Lee, J. H.
(2009). Dilemmas in Upper Gastrointestinal Cancers: Focus on Symptom Improvement. Am Soc Clin Oncol Ed Book
2009: 228-238
[Abstract][Full Text]
Kashani, A., Landaverde, C., Medici, V., Rossaro, L.
(2008). Fluid retention in cirrhosis: pathophysiology and management. QJM
101: 71-85
[Abstract][Full Text]
Ayantunde, A., Parsons, S.
(2007). Pattern and prognostic factors in patients with malignant ascites: a retrospective study. Ann Oncol
18: 945-949
[Abstract][Full Text]
Ferral, H., Gamboa, P., Postoak, D. W., Albernaz, V. S., Young, C. R., Speeg, K. V., McMahan, C. A.
(2004). Survival after Elective Transjugular Intrahepatic Portosystemic Shunt Creation: Prediction with Model for End-Stage Liver Disease Score. Radiology
231: 231-236
[Abstract][Full Text]
Gulyas, M, Kaposi, A D, Elek, G, Szollar, L G, Hjerpe, A
(2001). Value of carcinoembryonic antigen (CEA) and cholesterol assays of ascitic fluid in cases of inconclusive cytology. J. Clin. Pathol.
54: 831-835
[Abstract][Full Text]
Hauer, K. E., Winawer, N.
(2000). Update in Hospital Medicine. ANN INTERN MED
133: 707-713
[Full Text]
Rossle, M., Ochs, A., Gulberg, V., Siegerstetter, V., Holl, J., Deibert, P., Olschewski, M., Reiser, M., Gerbes, A. L.
(2000). A Comparison of Paracentesis and Transjugular Intrahepatic Portosystemic Shunting in Patients with Ascites. NEJM
342: 1701-1707
[Abstract][Full Text]
McNamara, P.
(2000). Paracentesis - an effective method of symptom control in the palliative care setting?. Palliat Med
14: 62-64
Tangkijvanich, P., Tresukosol, D., Sampatanukul, P., Sakdikul, S., Voravud, N., Mahachai, V., Mutirangura, A.
(1999). Telomerase Assay for Differentiating between Malignancy-related and Nonmalignant Ascites. Clin. Cancer Res.
5: 2470-2475
[Abstract][Full Text]
Ochs, A., Rossle, M., Haag, K., Hauenstein, K.-H., Deibert, P., Siegerstetter, V., Huonker, M., Langer, M., Blum, H. E.
(1995). The Transjugular Intrahepatic Portosystemic Stent-Shunt Procedure for Refractory Ascites. NEJM
332: 1192-1197
[Abstract][Full Text]
Kaufman, J. L., Gerbes, A.L., Scholmerich, J., Montero, E., Miguel, J., Lopez-Alvarez, J., Runyon, B. A.
(1994). Care of Patients with Ascites. NEJM
330: 1827-1828
[Full Text]
Previous
